CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 158 filers reported holding CONMED CORP in Q3 2015. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $31,000 | +72.2% | 419 | +1.9% | 0.01% | +40.0% |
| Q1 2017 | $18,000 | 0.0% | 411 | +0.2% | 0.01% | 0.0% |
| Q4 2016 | $18,000 | +12.5% | 410 | +0.5% | 0.01% | 0.0% |
| Q3 2016 | $16,000 | -15.8% | 408 | +0.5% | 0.01% | -16.7% |
| Q2 2016 | $19,000 | +11.8% | 406 | +0.5% | 0.01% | -14.3% |
| Q1 2016 | $17,000 | -5.6% | 404 | +0.5% | 0.01% | +16.7% |
| Q4 2015 | $18,000 | -5.3% | 402 | +0.5% | 0.01% | -14.3% |
| Q3 2015 | $19,000 | -17.4% | 400 | +0.3% | 0.01% | -12.5% |
| Q2 2015 | $23,000 | +15.0% | 399 | +0.5% | 0.01% | +14.3% |
| Q1 2015 | $20,000 | +11.1% | 397 | +0.3% | 0.01% | 0.0% |
| Q4 2014 | $18,000 | +20.0% | 396 | +0.5% | 0.01% | +16.7% |
| Q3 2014 | $15,000 | -11.8% | 394 | +0.5% | 0.01% | 0.0% |
| Q2 2014 | $17,000 | 0.0% | 392 | +0.5% | 0.01% | 0.0% |
| Q1 2014 | $17,000 | +6.2% | 390 | +0.5% | 0.01% | 0.0% |
| Q4 2013 | $16,000 | +23.1% | 388 | +0.5% | 0.01% | 0.0% |
| Q3 2013 | $13,000 | +8.3% | 386 | +0.3% | 0.01% | 0.0% |
| Q2 2013 | $12,000 | – | 385 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |